MDT

96.32

-0.43%↓

A

136.6

-0.54%↓

VEEV

223.99

-0.55%↓

HQY

91.8

-1.16%↓

PHR.US

16.86

-0.71%↓

MDT

96.32

-0.43%↓

A

136.6

-0.54%↓

VEEV

223.99

-0.55%↓

HQY

91.8

-1.16%↓

PHR.US

16.86

-0.71%↓

MDT

96.32

-0.43%↓

A

136.6

-0.54%↓

VEEV

223.99

-0.55%↓

HQY

91.8

-1.16%↓

PHR.US

16.86

-0.71%↓

MDT

96.32

-0.43%↓

A

136.6

-0.54%↓

VEEV

223.99

-0.55%↓

HQY

91.8

-1.16%↓

PHR.US

16.86

-0.71%↓

MDT

96.32

-0.43%↓

A

136.6

-0.54%↓

VEEV

223.99

-0.55%↓

HQY

91.8

-1.16%↓

PHR.US

16.86

-0.71%↓

Search

Quanterix Corp

Deschisă

SectorSănătate

6.35 1.44

Rezumat

Modificarea prețului

24h

Curent

Minim

6.22

Maxim

6.37

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+17.92% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

80M

318M

Deschiderea anterioară

4.91

Închiderea anterioară

6.35

Sentimentul știrilor

By Acuity

50%

50%

151 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 dec. 2025, 23:49 UTC

Achiziții, Fuziuni, Preluări

WiseTech to Sell Expedient to Appease Competition Regulator

30 dec. 2025, 17:12 UTC

Principalele dinamici ale pieței

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

30 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 dec. 2025, 21:16 UTC

Achiziții, Fuziuni, Preluări

Penguin Solutions: Smart Modular to Sell Zilia Stake for $46M

30 dec. 2025, 21:08 UTC

Market Talk

U.S. Natural Gas Futures Take Another Wild Ride -- Market Talk

30 dec. 2025, 20:41 UTC

Market Talk

Oil Futures Settle Lower in Sluggish Trade -- Market Talk

30 dec. 2025, 20:37 UTC

Câștiguri

The 5 Best Names to Play AI in 2026, According to Wall Street's Loudest Tech Bull -- Barrons.com

30 dec. 2025, 19:29 UTC

Market Talk

Corn Extends Pullback in Light Trade -- Market Talk

30 dec. 2025, 18:29 UTC

Market Talk

U.S. Oil Rig Count Rises By Three to 412 -- Market Talk

30 dec. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 dec. 2025, 16:20 UTC

Câștiguri

Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year. -- Barrons.com

30 dec. 2025, 16:18 UTC

Achiziții, Fuziuni, Preluări

Meta Buys AI Startup Manus, Adding Millions of Paying Users -- 2nd Update

30 dec. 2025, 16:10 UTC

Market Talk

Eurozone Government Bond Yields Rise, Euro Falls Ahead of Fed Minutes -- Market Talk

30 dec. 2025, 15:24 UTC

Market Talk

Australian Dollar Could Rise Versus Sterling -- Market Talk

30 dec. 2025, 15:10 UTC

Achiziții, Fuziuni, Preluări

Meta Stock Rises After Buying Manus. What the China-Founded AI Start-Up Brings. -- Barrons.com

30 dec. 2025, 14:24 UTC

Achiziții, Fuziuni, Preluări

LVMH: The Three Publications Are Challenges, Sciences & Avenir, and La Recherche

30 dec. 2025, 14:22 UTC

Achiziții, Fuziuni, Preluări

LVMH : Szafran Will Serve as Publishing Director For all Three Publications

30 dec. 2025, 14:20 UTC

Achiziții, Fuziuni, Preluări

LVMH: As Part of the Deal, Maurice Szafran Has Been Named President of Les Editions Croque Futur

30 dec. 2025, 14:17 UTC

Achiziții, Fuziuni, Preluări

LVMH: The Deal Also Reflects LVMH's Commitment to Support High-Quality Information and Scientific Culture

30 dec. 2025, 14:16 UTC

Achiziții, Fuziuni, Preluări

LVMH: The Deal Aims to Accelerate the Development and Distribution of the Publications Mainly in Digital Format

30 dec. 2025, 14:14 UTC

Achiziții, Fuziuni, Preluări

LVMH: The Move Includes Three Publications Into UFIPAR Investment Company

30 dec. 2025, 14:12 UTC

Achiziții, Fuziuni, Preluări

LVMH: Les Editions Croque Futur Is a French Publishing House

30 dec. 2025, 14:10 UTC

Achiziții, Fuziuni, Preluări

LVMH Acquires Les Editions Croque Futur

30 dec. 2025, 13:49 UTC

Achiziții, Fuziuni, Preluări

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

30 dec. 2025, 13:36 UTC

Market Talk

U.S. Natural Gas Continues Weather-Driven Rally -- Market Talk

30 dec. 2025, 13:30 UTC

Market Talk

Crude Futures Gain in Light Holiday Trade -- Market Talk

30 dec. 2025, 12:55 UTC

Market Talk

Triple Flag Precious Metals Offers Opportunity While Mitigating Risk -- Market Talk

30 dec. 2025, 11:55 UTC

Market Talk
Câștiguri

Investors Await Tesco's Profit Outlook Following U.K. Budget Reforms -- Market Talk

30 dec. 2025, 11:47 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Meta's Manus Deal Is a Taster of AI Trends for 2026. Watch This Risk. -- Barrons.com

30 dec. 2025, 11:35 UTC

Achiziții, Fuziuni, Preluări

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

17.92% sus

Prognoză pe 12 luni

Medie 7.5 USD  17.92%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

151 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat